Loading...
Chemical structure of Theliatinib

GC38081

Theliatinib

Also known as (3aR,6aR)-N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]-1-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole-5-carboxamide

Theliatinib (Xiliertinib) is a potent, ATP-competitive, orally active and highly selective EGFR inhibitor with a Ki of 0·05 nM and an IC50 of 3 nM· Theliatinib has an IC50 of 22 nM for EGFR T790M/L858R mutant· Theliatinib shows >50-fold selectivity for EGFR than other kinases· Anti-tumor activity

ChemicalCAS1353644-70-8MW442.51FormulaC25H26N6O2
CAS number
1353644-70-8
Molecular weight
442.51
Formula
C25H26N6O2
Solubility
DMSO： 5 mg/mL (11·30 mM)
InChIKey
FSXCKIBROURMFT-VGSWGCGISA-N
Catalogue number
GC38081
Brand
GLPBIO
Computed properties PubChem CID 54759275 · XLogP 3.1 · TPSA 82.6 Ų · H-bond donors 2
XLogP
3.1
TPSA
82.6 Ų
H-bond donors
2
H-bond acceptors
6
Rotatable bonds
5
Heavy atoms
33

SMILES CN1CC[C@H]2[C@@H]1CN(C2)C(=O)NC3=C(C=C4C(=C3)C(=NC=N4)NC5=CC=CC(=C5)C#C)OC

Computed descriptors from PubChem (CID 54759275), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.